BioSpace News Archive

Press Releases

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

October 28, 2026
·
8 min read
Press Releases

Humacyte Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent Covering Symvess and Other Bioengineered Tissues

October 28, 2026
·
6 min read
Press Releases

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

October 28, 2026
·
4 min read
Press Releases

Newron Pharmaceuticals to Participate in November 2026 Investor Conferences

October 28, 2026
·
3 min read
Press Releases

Scipher Medicine Launches PrismTcell™, the Next Molecular Treatment Response Signature, for Abatacept in Rheumatoid Arthritis

October 28, 2026
·
5 min read
Press Releases

TCG Labs Soleil Highlights Portfolio Momentum with Three Programs Entering First-in-Human Clinical Trials Across Oncology and Cardiovascular Disease

October 28, 2026
·
6 min read
Press Releases

INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement

October 28, 2026
·
5 min read
Press Releases

UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

October 28, 2026
·
10 min read
Press Releases

ORYZON to participate in upcoming events in November 2026

October 28, 2026
·
4 min read
Press Releases

Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial

October 28, 2026
·
2 min read